Related Experiment Video
Updated: Sep 2, 2025

Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics DCAF
Published on: September 17, 2019
Antibody dual-functionalisation enabled through a modular divinylpyrimidine disulfide rebridging strategy
Abigail R Hanby1, Stephen J Walsh1,2, Andrew J Counsell1
1Yusuf Hamied Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge, CB2 1EW, UK. spring@ch.cam.ac.uk.
We developed a new method for dual-functionalizing IgG antibodies using click chemistry. This approach avoids metal catalysts and purification, simplifying antibody modification for research and therapeutic applications.
Area of Science:
- Bioconjugation Chemistry
- Antibody Engineering
- Chemical Biology
Background:
- Antibody functionalization is crucial for developing targeted therapies and diagnostics.
- Existing methods often require metal catalysts or multiple purification steps, increasing complexity and cost.
Purpose of the Study:
- To develop a streamlined, metal-free methodology for the dual-functionalization of IgG antibodies.
- To enable sequential bioorthogonal reactions for precise antibody modification.
Main Methods:
- Utilized disulfide rebridging with divinylpyrimidine technology.
- Incorporated bicyclononyne and methylcyclopropene handles for sequential strain-promoted azide-alkyne cycloaddition (SPAAC) and ইনস্ট্যান্ট ইলেক্ট্রন ট্রান্সফার ডাইঅ্যাজোমেথেন অ্যাডিকেশন (IEDDA) reactions.
- Avoided metal catalysis and intermediate purification steps.
Main Results:
- Successfully achieved dual-functionalization of IgG antibodies in a single workflow.
- Demonstrated the compatibility of the method with sequential SPAAC and IEDDA reactions.
- Validated a metal-free and purification-free approach for antibody modification.
Conclusions:
- The developed methodology offers an efficient and versatile platform for IgG antibody dual-functionalization.
- This metal-free, purification-free strategy simplifies antibody engineering for various applications.
- Paves the way for more accessible and scalable antibody-based therapeutic and diagnostic development.
More Related Videos
10:17Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library
Published on: January 14, 2020
08:47Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates
Published on: March 6, 2019